Evaluation of influenza vaccine effectiveness among older adults in Jiaxing, China, 2022–2025: A test negative design-based study
Yang Liu, Xiaofei Fu, Yuanhang Wang, Lei Jia, LiJun Xu, Rui Li, Guoying Zhu, Haoyue Zhou · 2026
Read Evaluation of influenza vaccine effectiveness among older adults in Jiaxing, China, 2022–2025: A test negative design-based study by Yang Liu, Xiaofei Fu, Yuanhang Wang, Lei Jia, LiJun Xu, Rui Li, Guoying Zhu, Haoyue Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13217911.txt.
Description
Yang Liu and co-authors report a 2026 study of influenza vaccine performance in older adults in Jiaxing, China. The team followed patients aged 60 and over who sought care for acute respiratory symptoms across three flu seasons, from 2022 to 2025. Their question was how much protection the seasonal vaccine actually gave this age group.
Using a test-negative design with 3,214 participants, the researchers compared vaccination status between patients who tested positive for influenza and those who tested negative. Adjusted effectiveness came to 42.5 percent overall, peaking at 47.2 percent in the 2024-2025 season. Protection ran higher in women, in people without underlying illness, and in the first 90 days after vaccination, when it reached 52.3 percent. The authors conclude that timely annual vaccination still offers moderate, worthwhile protection for older adults.
Catalog record
| CREATOR | Yang Liu, Xiaofei Fu, Yuanhang Wang, Lei Jia, LiJun Xu, Rui Li, Guoying Zhu, Haoyue Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |